TRALI and TACO: Diagnosis, Recognition and Implementation of the AABB Guidelines
Program Code: 5404-TC
Tuesday, October 23, 2007
8:30 AM to 12:00 PM (ET)

MODERATOR
Mark A. Popovsky, MD, Haemonetics Corporation

SPEAKERS
Darrell Triulzi, MD, Institute of Transfusion Medicine
Patricia Kopko, MD, University of California, San Diego
Mark A. Popovsky, MD, Haemonetics Corporation
Kevin J. Land, MD, Bonfils Blood Center
Richard Benjamin, MD, PhD, American Red Cross
Pearl Toy, MD, UCSF
Mark Looney, MD, University of California, San Francisco
S. Breanndan Moore, MD, FRCPI, Mayo Clinic
Peter Tomasulo, MD, Blood Systems, Inc.

DESCRIPTION
TRALI is the number one cause of death from transfusion. The AABB has issued recommendations as to how to decrease this risk to recipients. This session will investigate the clinical distinctions and work-up of TRALI vs TACO, and explore why TACO is increasingly being recognized. New data on the value of questioning female donors vs. the effectiveness of HLA/granulocyte donor testing will be presented. Studies on 24-hour plasma vs. FFP will be presented. Blood centers and hospital collectors will discuss their plans to comply with the AABB recommendations.